Regenxbio (RGNX) Misses Q3 EPS by 12c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| Jennison Natural Resources Fund Class B (NASDAQ: RGNX) | Delayed: 7.16 -0.04 (0.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.20 | 52 Week High | $25.00 | |||
| Open | $7.27 | 52 Week Low | $7.07 | |||
| Day High | $7.46 | P/E | N/A | |||
| Day Low | $7.04 | EPS | $0.00 | |||
| Volume | 1,029,384 | |||||
